Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation
- 1 July 2003
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 163 (1), 303-312
- https://doi.org/10.1016/s0002-9440(10)63654-1
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Membrane lipids, EGF receptors, and intracellular signals colocalize and are polarized in epithelial cells moving directionally in a physiological electric fieldThe FASEB Journal, 2002
- Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand AvailabilityPublished by Elsevier BV ,2002
- Chemokines: agents for the immunotherapy of cancer?Nature Reviews Immunology, 2002
- Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokinesJournal of Allergy and Clinical Immunology, 2001
- Effector and regulatory T cells in allergic contact dermatitisTrends in Immunology, 2001
- Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent PathwayPublished by Elsevier BV ,2001
- EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XLOncogene, 1998
- EGF-Receptor Tyrosine Kinase Inhibition Induces Keratinocyte Growth Arrest and Terminal DifferentiationJournal of Investigative Dermatology, 1997
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- TGF-α Is Widely Expressed in Differentiated as well as Hyperproliferative Skin EpitheliumJournal of Investigative Dermatology, 1991